NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Potential bidders have backed away from Claire’s UK arm, stoking fears of a potential collapse as its US parent filed for bankruptcy protection in the US on Wednesday, Sky News understands.Read More